BACKGROUND: Gadolinium derivatives are ionic paramagnetic contrast agents used to enhance magnetic resonance images, labeled as a pregnancy category C by the Food and Drug Administration because of a lack of epidemiological studies concerning first-trimester exposure. METHODS: Prospective cohort study to determine whether gadolinium derivatives exposure in periconceptional period is a risk factor for pregnancy or fetal development. RESULTS: We report the outcome of 26 pregnant women exposed to gadolinium derivatives in the first trimester without adverse effect on pregnancy and neonatal outcome. CONCLUSIONS: Currently, this study represents the only prospective investigation of gadolinium derivatives in pregnancy, but more data are necessary to exclude a teratogenic risk.

De Santis, M., Straface, G., Cavaliere, A. F., Carducci, B., Caruso, A., Gadolinium Periconceptional exposure: pregnancy and neonatal outcome., <<ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA>>, 2007; (86 (1)): 99-101 [http://hdl.handle.net/10807/21974]

Gadolinium Periconceptional exposure: pregnancy and neonatal outcome.

De Santis;G; Cavaliere;Anna Franca; Carducci;Brigida; Caruso
2007

Abstract

BACKGROUND: Gadolinium derivatives are ionic paramagnetic contrast agents used to enhance magnetic resonance images, labeled as a pregnancy category C by the Food and Drug Administration because of a lack of epidemiological studies concerning first-trimester exposure. METHODS: Prospective cohort study to determine whether gadolinium derivatives exposure in periconceptional period is a risk factor for pregnancy or fetal development. RESULTS: We report the outcome of 26 pregnant women exposed to gadolinium derivatives in the first trimester without adverse effect on pregnancy and neonatal outcome. CONCLUSIONS: Currently, this study represents the only prospective investigation of gadolinium derivatives in pregnancy, but more data are necessary to exclude a teratogenic risk.
Inglese
De Santis, M., Straface, G., Cavaliere, A. F., Carducci, B., Caruso, A., Gadolinium Periconceptional exposure: pregnancy and neonatal outcome., <<ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA>>, 2007; (86 (1)): 99-101 [http://hdl.handle.net/10807/21974]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/21974
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact